Acknowledgement for APICES collaboration in study ABIDO published in » European Journal of Cancer»

APICES, Clinical Trials, Metastatic castration-resistant prostate cancer, Project management, Publications, Randomised

This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial”. published in…

Acknowledgement for APICES collaboration in DART 01/05 study published in «The Lancet Oncology»

Androgen deprivation therapy, APICES, Clinical Trials, Phase III, Prostate cancer, Publications, Radiotherapy, Randomised

Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial”. This is an extra motivation for the whole APICES team. These achievements would not be…